Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III trial of F-genotype live attenuated mumps vaccine in healthy children aged 5-11 years
CTR20201943Phase 3Active
- Sponsor
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Start
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of mumps vaccine, live (human diploid cell) in mumps, sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Started Sep 2020; status: active.
02
Drugs
mumps vaccine, live (human diploid cell)
03
Conditions
mumps
Beyond the preview
Go deeper on CTR20201943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201943.